Thymoglobulin reverses acute renal allograft rejection better than ATGAM—A double-blinded randomized clinical trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 1997-11, Vol.29 (7), p.21S-23S
Hauptverfasser: Tesi, R.J., Kano, J.M., Horn, H.R., Schroeder, T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 23S
container_issue 7
container_start_page 21S
container_title Transplantation proceedings
container_volume 29
creator Tesi, R.J.
Kano, J.M.
Horn, H.R.
Schroeder, T.
description
doi_str_mv 10.1016/S0041-1345(97)80005-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79413988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S004113459780005X</els_id><sourcerecordid>79413988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-76cd2c59c871e42cf4e62e82bd21d22c2a6d917237129eaac8a2e31739d7bc263</originalsourceid><addsrcrecordid>eNqFkMFuFSEUhonR1Gv1EZrMwpi6GIXD3AFW5qbRalLjwmvSHWHgTEvDDBWYJnXlQ_iEPom09-ZuXcHhfOcHPkJOGH3HKOvff6e0Yy3j3fpUibeSUrpuL5-QFZOCt9ADf0pWB-Q5eZHzTWU66PgROVK87xXAiizb6_spXoU4LMHPTcI7TBlzY-xSsJazCY0JIV4lM5Za36AtPs7NgKVgasq1mZvN9nzz9e_vP5vGxWUI2A41yqFrkpldnPyvurX1yNsaVpI34SV5NpqQ8dV-PSY_Pn3cnn1uL76dfznbXLSWS1Va0VsHdq2sFAw7sGOHPaCEwQFzABZM7xQTwAUDhcZYaQA5E1w5MVjo-TF5s8u9TfHngrnoyWeLIZgZ45K1UB3jSsoKrnegTTHnhKO-TX4y6V4zqh9060fd-sGlVkI_6taXde5kf8EyTOgOU3u_tf963ze5_n6sRqzPBwyoolzSin3YYVhl3HlMOluPs0XnUxWuXfT_ecg_pCae1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79413988</pqid></control><display><type>article</type><title>Thymoglobulin reverses acute renal allograft rejection better than ATGAM—A double-blinded randomized clinical trial</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tesi, R.J. ; Kano, J.M. ; Horn, H.R. ; Schroeder, T.</creator><creatorcontrib>Tesi, R.J. ; Kano, J.M. ; Horn, H.R. ; Schroeder, T.</creatorcontrib><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/S0041-1345(97)80005-X</identifier><identifier>PMID: 9366922</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acute Disease ; Adolescent ; Adult ; Aged ; Animals ; Antilymphocyte Serum - therapeutic use ; Biological and medical sciences ; Double-Blind Method ; Female ; Graft Rejection - therapy ; Humans ; Immunomodulators ; Kidney Transplantation - immunology ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Rabbits</subject><ispartof>Transplantation proceedings, 1997-11, Vol.29 (7), p.21S-23S</ispartof><rights>1997 Elsevier Science Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-76cd2c59c871e42cf4e62e82bd21d22c2a6d917237129eaac8a2e31739d7bc263</citedby><cites>FETCH-LOGICAL-c389t-76cd2c59c871e42cf4e62e82bd21d22c2a6d917237129eaac8a2e31739d7bc263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S004113459780005X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2090380$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9366922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tesi, R.J.</creatorcontrib><creatorcontrib>Kano, J.M.</creatorcontrib><creatorcontrib>Horn, H.R.</creatorcontrib><creatorcontrib>Schroeder, T.</creatorcontrib><title>Thymoglobulin reverses acute renal allograft rejection better than ATGAM—A double-blinded randomized clinical trial</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><subject>Acute Disease</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>Antilymphocyte Serum - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Graft Rejection - therapy</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Kidney Transplantation - immunology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFuFSEUhonR1Gv1EZrMwpi6GIXD3AFW5qbRalLjwmvSHWHgTEvDDBWYJnXlQ_iEPom09-ZuXcHhfOcHPkJOGH3HKOvff6e0Yy3j3fpUibeSUrpuL5-QFZOCt9ADf0pWB-Q5eZHzTWU66PgROVK87xXAiizb6_spXoU4LMHPTcI7TBlzY-xSsJazCY0JIV4lM5Za36AtPs7NgKVgasq1mZvN9nzz9e_vP5vGxWUI2A41yqFrkpldnPyvurX1yNsaVpI34SV5NpqQ8dV-PSY_Pn3cnn1uL76dfznbXLSWS1Va0VsHdq2sFAw7sGOHPaCEwQFzABZM7xQTwAUDhcZYaQA5E1w5MVjo-TF5s8u9TfHngrnoyWeLIZgZ45K1UB3jSsoKrnegTTHnhKO-TX4y6V4zqh9060fd-sGlVkI_6taXde5kf8EyTOgOU3u_tf963ze5_n6sRqzPBwyoolzSin3YYVhl3HlMOluPs0XnUxWuXfT_ecg_pCae1A</recordid><startdate>19971101</startdate><enddate>19971101</enddate><creator>Tesi, R.J.</creator><creator>Kano, J.M.</creator><creator>Horn, H.R.</creator><creator>Schroeder, T.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19971101</creationdate><title>Thymoglobulin reverses acute renal allograft rejection better than ATGAM—A double-blinded randomized clinical trial</title><author>Tesi, R.J. ; Kano, J.M. ; Horn, H.R. ; Schroeder, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-76cd2c59c871e42cf4e62e82bd21d22c2a6d917237129eaac8a2e31739d7bc263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Acute Disease</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>Antilymphocyte Serum - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Graft Rejection - therapy</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Kidney Transplantation - immunology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tesi, R.J.</creatorcontrib><creatorcontrib>Kano, J.M.</creatorcontrib><creatorcontrib>Horn, H.R.</creatorcontrib><creatorcontrib>Schroeder, T.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tesi, R.J.</au><au>Kano, J.M.</au><au>Horn, H.R.</au><au>Schroeder, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thymoglobulin reverses acute renal allograft rejection better than ATGAM—A double-blinded randomized clinical trial</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>1997-11-01</date><risdate>1997</risdate><volume>29</volume><issue>7</issue><spage>21S</spage><epage>23S</epage><pages>21S-23S</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9366922</pmid><doi>10.1016/S0041-1345(97)80005-X</doi></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 1997-11, Vol.29 (7), p.21S-23S
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_79413988
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acute Disease
Adolescent
Adult
Aged
Animals
Antilymphocyte Serum - therapeutic use
Biological and medical sciences
Double-Blind Method
Female
Graft Rejection - therapy
Humans
Immunomodulators
Kidney Transplantation - immunology
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Rabbits
title Thymoglobulin reverses acute renal allograft rejection better than ATGAM—A double-blinded randomized clinical trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T20%3A58%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thymoglobulin%20reverses%20acute%20renal%20allograft%20rejection%20better%20than%20ATGAM%E2%80%94A%20double-blinded%20randomized%20clinical%20trial&rft.jtitle=Transplantation%20proceedings&rft.au=Tesi,%20R.J.&rft.date=1997-11-01&rft.volume=29&rft.issue=7&rft.spage=21S&rft.epage=23S&rft.pages=21S-23S&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/S0041-1345(97)80005-X&rft_dat=%3Cproquest_cross%3E79413988%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79413988&rft_id=info:pmid/9366922&rft_els_id=S004113459780005X&rfr_iscdi=true